Skip to main content
Fig. 4 | Molecular Medicine

Fig. 4

From: Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness

Fig. 4

– Ex Vivo Experiments with BTLA Fusion Protein: When cells came from mice with critical illness there were increased levels of IL-6 (p = 0.41, Figure a), IL-9 (p = 0.019, Figure b), IL-27 (p = 0.044, Figure c) and cellular proliferation (p = 0.004, Figure d). The addition of 1000 ng/mL of BTLA fusion protein also increased cellular proliferation (p = 0.021, Figure d)

Back to article page